Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9975228 | The Journal of Heart and Lung Transplantation | 2005 | 9 Pages |
Abstract
Use and application of induction therapy continues to be controversial in heart transplantation. At present, this approach appears to be beneficial in selected patients who are at high risk for rejection death, but likely detrimental in patients who are at low risk for rejection death. Those with a combination of longer term VAD support, of black ethnicity, and having extensive HLA mismatching are most likely to benefit from cytolytic induction therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
R. MD, J.K. MD, R.N. BS, B.K. MD, L. MD, R. MD, L. MD, M. MD, R.C. MD, Cardiac Transplant Research Database (CTRD) Cardiac Transplant Research Database (CTRD),